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http://dx.doi.org/10.1016/j.jfma.201Diffuse sclerosing papillary thyroid carcinoma (DSPTC) is a relatively rare variant of papillary
thyroid carcinomawith distinct histological features, radiological characteristics, and biological
aggressiveness. Compared with conventional papillary thyroid carcinoma, DSPTC is character-
ized by scattered microscopic tumor islands, diffuse fibrosis, calcification, and abundant
lymphocytic aggregation. A preoperative diagnosis is challenging in the absence of nodules
and scanty fine needle aspiration cytology samples. We describe a unique DSPTC patient, an
18-year-old woman who presented with a neck mass that grew slowly for 2 years. The palpable
neckmasswas nontender, well defined, firm, and unmovable. Laboratory studies showed normal
thyroid function and positive autoimmune markers: antithyroglobulin antibody Z 1:1600 and
antimicrosomal antibodyZ 1:1600. A neck ultrasound showed diffusely prominent microcalcifi-
cations with one small vague nodule. Hashimoto’s thyroiditis with an accompanying malignancy
was suspected. Based on the result of intraoperative pathology reports, the patient was given
a total thyroidectomy. Lymph node dissection and histological analysis revealed bilateral DSPTC
in addition to lymphocytic thyroiditis in nonmalignant areas of the thyroid. Clinical and histolog-
ical diagnostic challenges usually occur when DSPTC presents with a diffuse thyroid enlarge-
ment, dispersed microscopic tumor islands (frequently without mass formation), extensive
fibrosis, and abundant lymphocytic infiltration mimicking thyroiditis.
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Papillary carcinoma is the most common malignant
neoplasm of the thyroid gland. Histological variants of
papillary thyroid carcinoma (PTC) are well known and are
usually classified as “biologically aggressive” or “biologi-
cally indolent.”1,2 Diffuse sclerosing papillary thyroid
carcinoma (DSPTC) is a rare variant of PTC with distinct
characteristics and is recognized as biologically aggressive.
DSPTC occurs at a younger age and has a higher incidence of
cervical lymph node metastasis than conventional PTC.3
Ultrasound findings of DSPTC also reveal diagnostic
features: diffuse scattered microcalcifications with or
without associated mass in most cases.4 Fine needle aspi-
ration cytology of DSPTC always reveals numerous psam-
moma bodies (microcalcifications) in cellular fragments and
dispersed microscopic tumor islands of sheets or follicular
structures in a lymphocyte-rich background,5,6 while
Hashimoto’s thyroiditis shows abundant lymphocytic infil-
tration and prominent Hurthle cell changes in follicular
cells. Because DSPTC always permeates the entire gland,
which causes diffuse thyroid enlargement without a domi-
nant nodule, and because histological analysis shows
copious inflammation and scattered microscopic tumor
islands, the preoperative diagnosis of DSPTC is challenging,
whether or not combined with Hashimoto’s thyroiditis.
We present a unique case of DSPTC with characteristic
ultrasound findings, cytological and histological correla-
tion, and biological behavior, and discuss its clinical eval-
uation and diagnosis.
Case report
In July 2006, an 18-year-old woman presented at National
Cheng-Kung University Hospital with a neck mass that had
grown slowly for 2 years. The size of the mass had not
changed, but the texture had become firm. The patient did
not have any unusual heart palpitations or body tremors,
nor had she experienced any change in body weight or poor
appetite. She stated that she had difficulty swallowing
when she was lying down, that she had recently noticed
that she was losing more hair, and that the neck mass was
sometimes tender. The patient had no family history of
thyroid disease, nor a personal history related to a pre-
existing thyroid pathologic process or previous irradiation
to the neck region.
A physical examination revealed a diffuse palpable
middle-neck mass protruding on both sides. The mass was
nontender, well-defined, firm, and immovable. An initial
ultrasound showed generally enlarged thyroid lobes with
diffusely prominent microcalcifications and one vague
nodular lesion in the right thyroid lobe (Fig. 1A and B). It
also showed enlarged bilateral neck lymph nodes and
diffuse microcalcifications similar to those in the bilateral
thyroid lobes (Fig. 1C). Thus, fine needle aspiration
cytology was performed, which showed atypical cells in flat
sheets and clusters with nuclear enlargement, vesicular
nuclei, irregular nuclear borders, and abundant cytoplasm
(Fig. 2A). Although longitudinal nuclear grooves and intra-
nuclear cytoplasmic inclusions were not shown, a malig-
nancy was highly suspected. A serological analysis showednormocytic anemia (Hb: 9.9 g/dL) and normal thyroid
marker valuesdfree T4: 1.24 ng/dL (normal: 0.9e2.0 ng/
dL), T3: 72.22 ng/dL (normal: 85e202 ng/dL), T4: 8.13 g/dL
(normal: 5.1e14.1 ng/dL), and thyroid-stimulating
hormone (TSH): 0.668 mIU/L (normal: 0.27e4.2 mIU/L)d
with positive antithyroglobulin antibody (1:1600) and anti-
microsomal antibody (1:1600). Hence, Hashimoto’s
thyroiditis with a suspected accompanying malignancy was
the initial diagnosis. A total thyroidectomy and bilateral
neck lymph node dissection were performed, and an
intraoperative pathology consultation proved its malig-
nancy (lymph node metastasis). The total thyroid glands
and bilateral neck lymph nodes were submitted for a path-
ological examination. Microscopically, all lobes of the
thyroid and bilateral lymph nodes contained tumor cells
and showed diffuse stromal fibrosis, prominent lymphocytic
infiltration, and numerous psammoma-type calcifications.
Postoperative thyroid function tests consistently indi-
cated hypothyroidism; therefore, the patient was given
supplements of oral thyroxine (100 mg/d), which she still
continues to take. Interestingly, postoperative levels of
antithyroglobulin antibody and antimicrosomal antibody
gradually diminished and have been undetectable since 5
months after surgery. Moreover, the patient underwent one
postoperative radioiodine ablation therapy for lymph node
metastasis. Although the tumor initially metastasized to
the cervical lymph nodes, at a 3-year follow-up, the
patient’s chest X-ray was normal and we found no evidence
of distal metastasis.Pathology findings
All tissue samples obtained during surgery were fixed in 10%
buffered formalin and processed for histopathologic exami-
nation using standard methods. Tissue sections (4 mm thick)
were stained with hematoxylin and eosin (H&E). The speci-
mens consisted of tissue from the bilateral thyroid lobes,
pyramidal lobe, and bilateral neck lymph nodes. The right
lobe, pyramidal lobe, and left lobe measured 7  4  3,
1.2  0.7  0.5, and 6  3  3 cm3, respectively. When cut,
they were firm with diffuse calcifications. In the serial
sections, there was one vague, small (about 0.8  0.7 cm2)
nodule in the right lobe (Fig. 1D). The remainder of the right
lobe and the other lobes of thyroid were diffusely fibrotic,
tan-to-white in color, and without any nodular masses.
Histological analysis showed diffuse squamoid tumor
nests of DSPTC in all three lobes of the thyroid, diffuse and
prominent stromal fibrosis, prominent lymphocytic infil-
tration with lymphoid follicle formation, and numerous
psammoma bodies (Fig. 2B and C). There were many tumor
emboli of small papillary structures in the lymphatic
channels (Fig. 2D). A cytological analysis of the DSPTC
tumor cells revealed large nucleoli, pale nuclei, and
abundant cytoplasm in squamoid nests and follicular
structures (Fig. 3A), different from the classical cytology of
PTC. Only the small, vague, nodular lesion of the right
thyroid lobe appears similar to a conventional papillary
carcinoma (Fig. 3B and C), which has nuclear grooves,
intranuclear inclusions, and ground glass nuclei in its
papillary and follicular structures. The non-neoplastic
follicles were also infiltrated by dense lymphocytic
Figure 1 Bilateral (A: right-transverse view; B: left-longitudinal view) enlarged thyroid lobes with diffusely bilateral prominent
microcalcifications and one vague mass of right thyroid (white arrow). Bilateral enlarged lymph nodes (C: right-transverse view)
also reveal diffuse microcalcifications. The right perithyroid lymph node is 1.11  0.67 cm2. (D) The only vague small nodule (black
arrow; about 0.8  0.7 cm2) in the right lobe in the thyroid. Except for the nodular lesion, the thyroid was firm and fibrotic.
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changes in these areas. The lymph nodes (pretracheal: 6/7;
right neck: 8/10; and left neck: 8/11) contained extensively
metastatic carcinoma characterized by squamoid nests of
tumor cells in a sclerosing background and numerous
psammoma bodies (microcalcifications) (Fig. 3D), which
correspond to the ultrasound findings for lymph nodes.Discussion
We reported the case of a patient presenting with normal
thyroid function, positive antithyroglobulin antibody and
antimicrosomal antibody, and diffuse thyroid enlargement,
resembling Hashimoto’s thyroiditis but postoperatively
confirmed as DSPTC. Although DSPTC is rare, it is important
for physicians to recognize and consider the possibility of
this disease because of its clinical resemblance to Hashi-
moto’s thyroiditis.7,8 In one series of 14 patients,7 four
cases were misdiagnosed and treated as Hashimoto’s
thyroiditis for a mean period of 3.8 years. In the absence of
a nodular mass or an atypical cell in fine needle aspirationcytology samples, the clinical presentation may result in
a misdiagnosis.
In our patient’s thyroid function tests prior to operation,
relatively low T3 level was noted with normal T4 and TSH.
Hence, we further checked her free T4 level, which was
normal again. Since then, low T3 syndrome describing
a situation characterized by lowered T3 levels with normal
thyroid gland activity was also taken into differential
diagnosis. Low T3 syndrome is the most common form of
euthyroid sick syndrome which is divided into three
typesdlow T3 syndrome, low T3 and T4 syndrome, and low
TSH syndrome.9 Euthyroid sick syndrome represents
abnormalities of thyroid hormone concentrations associ-
ated with a wide variety of nonthyroidal illnesses. Except
thyroid malignancy, our patient had no specific underlying
disease or medication. Furthermore, the low T3 level prior
to operation may be appropriately taken as an additional
finding probably associated with underlying malignancy.
In a series of 30 cases,10 DSPTC occurred at a signifi-
cantly younger age (mean age: 30.4 years), showed some
lymph node metastasis (in five of 30), recurred more
frequently (in nine of 30), was more likely to manifest
Figure 2 (A) Fine needle aspiration cytology (Papanicolaou’s stain, 400) revealed atypical cells in flat sheets and clusters. The
atypical cells show overlapping of nuclei, enlarged vesicular nuclei, irregular and distinct nuclear borders, and abundant cyto-
plasm. Longitudinal nuclear grooves and intranuclear cytoplasmic inclusions are not obviously shown. The background is
lymphocyte rich. (B and C) Squamoid tumor nests diffusely distributed in all thyroid lobes with dense stromal fibrosis, prominent
lymphocytic infiltration with lymphoid follicle formation, and numerous psammoma bodies (H&E stain, 40). (D) Tumor emboli of
small papillary structures in the lymphatic channels (H&E stain, 200). H&E Z hematoxylin and eosin.
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survival (60.9% in a 10-year follow-up), and expressed
a higher incidence of positive antithyroglobulin antibody
(72%, 23 of 32) in comparison with all other PTC variants.
Our patient presented with most of the typical character-
istics. Because it is an aggressive cancer that clinically
mimics Hashimoto’s thyroiditis, a thorough clinical evalua-
tion is important for avoiding a misdiagnosis and
mistreatment.
Ultrasound evaluation may be helpful initially because
the diagnostic features of DSPTC include a heterogeneous
echotexture, solid composition, ill-defined margins, and
diffuse microcalcifications with a snowstorm appearance in
thyroid lobes with or without an associated mass in most
cases,4,5 which corresponds to our findings (Fig. 1A and B).
The diffuse nature of DSPTC often mimics chronic thyroid-
itis on ultrasound images and leads to treatment delay,
especially in the absence of a nodular mass. The most
important ultrasound features may be snowstorm-like
microcalcifications in enlarged lymph nodes (Fig. 1C),
which is characteristic of DSPTC, even when there are no
significant thyroid nodular lesions.
Fine needle aspiration cytology of DSPTC tumors always
reveals numerous psammoma bodies, abundant lympho-
cytes, metaplastic squamoid cells, and the absence of
stringy colloids together with few epithelial cells that show
the classical features of papillary carcinoma, such as
nuclear grooves, intranuclear inclusions, and ground glass
nuclei.5,6 The patient in our case showed clusters ofatypical epithelial cells in a lymphocyte-rich background
with abundant cytoplasm, enlarged vesicular nuclei, and
irregular nuclear shapes. Although the nuclear grooves and
intranuclear cytoplasmic inclusions were not obvious,
a malignancy was highly suspected. Moreover, sampling
failures and misinterpretations of diffuse tumor cells may
occur in DSPTC cases because clinicians may take scanty
and unrepresentative tissue samples randomly from
a diffuse fibrotic, inflamed, and microcalcified thyroid,
especially in the absence of significant nodular mass.
Hence, the sensitivity rate of fine needle aspiration
cytology for those without nodular lesions may not be as
high as in the cases reported in the literature.5,6
For the general treatment of PTC, a total thyroidectomy
or bilateral lobar resection results in fewer recurrences
than a lobectomy. DSPTC treatment in our center uses the
same protocol as is used for ordinary PTC: a total thyroid-
ectomy and then radioiodine or external radiotherapy in
selected cases. The good clinical outcome in our DSPTC
case might have been related to the patient’s youth, the
treatment, or both.
A general concern when following up PTC is that thyro-
globulin is a sensitive and specific serum marker for
detecting relapses. However, its effectiveness is limited by
the presence of antithyroglobulin autoantibody, which may
interfere with thyroglobulin assays. The high level of
antithyroglobulin autoantibody (72e75%) in DSPTC7,8,10,11
may render it less useful as a tumor marker after radio-
iodine ablation. Also, our young patient initially had high
Figure 3 (A) Cytology of DSPTC tumor cells reveals large nucleoli, pale nuclei, and abundant cytoplasm in squamoid nests and
follicular structures (H&E stain, 400). (B) The vague nodular lesion in the right thyroid appears similar to a conventional papillary
carcinoma in papillary and follicular structures (H&E stain, 40). (C) Tumor cells in the vague nodular lesion of the right thyroid
show nuclear grooves, intranuclear inclusions, and ground glass nuclei (H&E stain, 400). (D) Metastatic carcinomas in lymph nodes
reveal squamoid nests of tumor cells in a sclerosing background and numerous microcalcifications, which are characteristic of
DSPTC (H&E stain, 40). H&E Z hematoxylin and eosin.
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but their postoperative levels gradually diminished and
have been undetectable since 5 months post-surgery. Apart
from this, the follow-up for patients with DSPTC is similar
to that for patients with other PTC variants.
In conclusion, because patients with DSPTC may present
with typical clinicopathological features and initially
appear to have Hashimoto’s thyroiditis, a thorough clinical
evaluation and an early diagnosis are important. DSPTC
generally has a greater tendency for lymph node metastasis
and distant metastasis, and worse disease-free survival
than other PTC variants. Complete surgical treatment and
postoperative radioiodine ablation are recommended, and
a close follow-up is necessary.
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